NasdaqCM:XBIOBiotechs
Xenetic Biosciences First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
Xenetic Biosciences ( NASDAQ:XBIO ) First Quarter 2025 Results Key Financial Results Revenue: US$593.3k (up 16% from 1Q...
Stock Analysis
Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.